Randomized controlled trial of telephone monitoring with psychiatry inpatients with co-occurring substance use and mental health disorders.
Adult
Ambulatory Care
/ methods
Comorbidity
Diagnosis, Dual (Psychiatry)
Female
Follow-Up Studies
Humans
Inpatients
/ psychology
Longitudinal Studies
Male
Mental Disorders
/ epidemiology
Mental Health
/ trends
Middle Aged
Patient Discharge
/ trends
Psychiatry
/ methods
Substance-Related Disorders
/ epidemiology
Telephone
12-Step groups
Co-occurring
Mental health
Substance use
Telephone monitoring
Journal
Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587
Informations de publication
Date de publication:
01 01 2019
01 01 2019
Historique:
received:
18
04
2018
revised:
13
09
2018
accepted:
14
09
2018
pubmed:
23
11
2018
medline:
26
4
2019
entrez:
23
11
2018
Statut:
ppublish
Résumé
Background Psychiatry inpatients frequently have co-occurring substance use and mental health disorders, which are related to poor post-discharge outcomes. Telephone monitoring is effective in specialty substance use disorder treatment settings in increasing continuing care and 12-step program utilization and improving substance use outcomes. This study examined the effectiveness of telephone monitoring among psychiatry inpatients with co-occurring substance use and mental health disorders. Methods This randomized controlled trial (n = 406) compared usual care to usual care plus telephone monitoring (one in-person session during the inpatient stay, followed by weekly telephone contact for three months post-discharge). Follow-ups were conducted at end-of-intervention (three months post-baseline) and nine and 15 months post-baseline (73% followed). Primary outcomes were number of days out of the past 30 of drinking alcohol, using drugs, and experiencing psychological problems. Secondary outcomes were outpatient substance use treatment, and 12-step group, utilization. Results Longitudinal modeling found that patients in both conditions improved over time on each primary outcome. Improvement was comparable between conditions on alcohol and drug use and psychological problems. Receipt of outpatient treatment decreased over the follow-up period and was not related to condition. Likelihood of attending 12-step group meetings did not change over follow-ups, and was not related to condition. Conclusions Improvement over time was evident regardless of condition assignment. Patients maintained attendance at 12-step groups from pre- to post-discharge. Short-term telephone monitoring in addition to usual care for patients with co-occurring substance use and mental health disorders may not be sufficiently intensive to achieve additional improvements on outcomes.
Identifiants
pubmed: 30466040
pii: S0376-8716(18)30745-2
doi: 10.1016/j.drugalcdep.2018.09.010
pmc: PMC6448768
mid: NIHMS1014472
pii:
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
230-237Subventions
Organisme : HSRD VA
ID : IAC 09-055
Pays : United States
Organisme : HSRD VA
ID : RCS 00-001
Pays : United States
Organisme : HSRD VA
ID : RCS 14-232
Pays : United States
Informations de copyright
Published by Elsevier B.V.
Références
Addict Behav. 1999 Jan-Feb;24(1):17-35
pubmed: 10189970
Alcohol Clin Exp Res. 2001 Jan;25(1):128-35
pubmed: 11198708
J Am Geriatr Soc. 1992 Sep;40(9):922-35
pubmed: 1512391
J Stud Alcohol. 2004 Mar;65(2):274-82
pubmed: 15151360
J Consult Clin Psychol. 2004 Dec;72(6):967-79
pubmed: 15612844
Arch Gen Psychiatry. 2005 Feb;62(2):199-207
pubmed: 15699297
Am J Addict. 2006 Mar-Apr;15(2):113-24
pubmed: 16595348
Curr Opin Psychiatry. 2007 Jul;20(4):353-8
pubmed: 17551350
J Consult Clin Psychol. 2007 Oct;75(5):775-84
pubmed: 17907859
Psychiatr Serv. 2008 Sep;59(9):982-8
pubmed: 18757590
J Affect Disord. 2009 Jan;112(1-3):50-8
pubmed: 18945495
Am J Manag Care. 2008 Dec;14(12):841-6
pubmed: 19067501
Recent Dev Alcohol. 2008;18:303-20
pubmed: 19115776
Harv Rev Psychiatry. 2009;17(1):24-34
pubmed: 19205964
Addict Behav. 2010 Apr;35(4):350-4
pubmed: 20053503
J Consult Clin Psychol. 2010 Dec;78(6):912-23
pubmed: 20873894
Med Care. 2011 Jan;49(1):76-88
pubmed: 20966778
J Psychiatr Ment Health Nurs. 2010 Dec;17(10):862-72
pubmed: 21078001
Drug Alcohol Depend. 2011 Nov 1;118(2-3):194-201
pubmed: 21515004
Addiction. 2011 Oct;106(10):1760-9
pubmed: 21545667
Arch Gen Psychiatry. 2011 Jun;68(6):577-84
pubmed: 21646576
Addict Behav. 2012 Jan;37(1):11-24
pubmed: 21981788
J Subst Abuse Treat. 2012 Sep;43(2):137-51
pubmed: 22301087
Curr Opin Psychiatry. 2012 May;25(3):194-200
pubmed: 22395768
Gen Hosp Psychiatry. 2012 Sep-Oct;34(5):450-9
pubmed: 22632925
Addict Behav. 2012 Oct;37(10):1069-74
pubmed: 22651986
J Subst Abuse Treat. 2013 Feb;44(2):216-23
pubmed: 22763197
Psychiatr Serv. 2013 Jan;64(1):13-20
pubmed: 23117443
J Subst Abuse Treat. 2013 May-Jun;44(5):473-80
pubmed: 23217610
Drug Alcohol Depend. 2014 Feb 1;135:78-87
pubmed: 24342419
Addict Behav. 2014 Mar;39(3):660-8
pubmed: 24355401
J Subst Abuse Treat. 2014 Apr;46(4):403-11
pubmed: 24462479
Psychiatr Q. 2015 Sep;86(3):355-71
pubmed: 25433455
J Psychiatr Ment Health Nurs. 2015 Apr;22(3):171-82
pubmed: 25707898
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):99-111
pubmed: 25747923
Addiction. 2015 Sep;110(9):1417-9
pubmed: 26223170
J Subst Abuse Treat. 2016 Feb;61:47-59
pubmed: 26531892
Drug Alcohol Depend. 2016 Jan 1;158:38-44
pubmed: 26621551
Psychiatr Serv. 2017 Jan 1;68(1):92-95
pubmed: 27582241
JAMA Psychiatry. 2016 Nov 1;73(11):1119-1126
pubmed: 27654151
Psychiatr Serv. 2017 Feb 1;68(2):151-158
pubmed: 27745535
J Ment Health. 2017 Mar 10;:1-6
pubmed: 28282996
J Evid Inf Soc Work. 2017 May-Jun;14(3):201-215
pubmed: 28459377
Am J Addict. 2017 Sep;26(6):602-609
pubmed: 28570773
Can J Psychiatry. 2017 Aug;62(8):551-559
pubmed: 28616935
Contemp Clin Trials. 2017 Sep;60:105-112
pubmed: 28689852
Health Aff (Millwood). 2017 Oct 1;36(10):1739-1747
pubmed: 28971918
Int J Ment Health Addict. 2018;16(1):53-65
pubmed: 29491766
Cochrane Database Syst Rev. 2018 Apr 24;4:CD008581
pubmed: 29688573